Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sage Therapeutic Com (SAGE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,865,939
  • Shares Outstanding, K 46,890
  • Annual Sales, $ 0 K
  • Annual Income, $ -270,120 K
  • 36-Month Beta 2.62
  • Price/Sales 65.22
  • Price/Cash Flow N/A
  • Price/Book 5.91

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -2.84
  • Number of Estimates 12
  • High Estimate -2.33
  • Low Estimate -3.20
  • Prior Year -1.75
  • Growth Rate Est. (year over year) -62.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
79.88 +69.00%
on 12/24/18
158.59 -14.87%
on 01/07/19
+33.01 (+32.37%)
since 12/14/18
3-Month
79.88 +69.00%
on 12/24/18
158.59 -14.87%
on 01/07/19
+10.52 (+8.45%)
since 10/16/18
52-Week
79.88 +69.00%
on 12/24/18
195.97 -31.11%
on 01/31/18
-33.35 (-19.81%)
since 01/16/18

Most Recent Stories

More News
Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus

It was a busy week for the biotech sector with most companies gaining on M&A activity. The annual J.P. Morgan Healthcare conference were also a key area of focus.

CELG : 87.96 (-0.31%)
ALNY : 82.10 (+2.05%)
LOXO : 233.48 (-0.08%)
SAGE : 133.90 (+1.49%)
GILD : 68.24 (-0.41%)
REGN : 404.74 (-0.07%)
BIIB : 335.85 (-0.50%)
Report: Developing Opportunities within General Mills, Philip Morris International, Sage Therapeutics, CNA Financial, Hess, and AutoNation -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of General Mills, Inc. (NYSE:GIS),...

GIS : 41.98 (+0.19%)
CNA : 45.05 (-0.42%)
HES : 51.64 (-0.35%)
SAGE : 133.90 (+1.49%)
PM : 69.46 (-1.48%)
AN : 37.08 (+0.62%)
Sage Therapeutics Announces SAGE-217 Meets Primary and Secondary Endpoints in Phase 3 Clinical Trial in Postpartum Depression

--- Well-tolerated with rapid onset of statistically significant effect (Day 3) through two weeks and maintained for four weeks after treatment -

SAGE : 133.90 (+1.49%)
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sage Therapeutics(NASDAQ:SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that,...

SAGE : 133.90 (+1.49%)
22.5% Return Seen to Date on SmarTrend Sage Therapeutic Call (SAGE)

SmarTrend identified a Downtrend for Sage Therapeutic (NASDAQ:SAGE) on November 13th, 2018 at $113.70. In approximately 2 months, Sage Therapeutic has returned 22.50% as of today's recent price of $88.11....

SAGE : 133.90 (+1.49%)
Implied Volatility Surging for Sage Therapeutics (SAGE) Stock Options

Sage Therapeutics (SAGE) needs investors to pay close attention to the stock based on moves in the options market lately.

SAGE : 133.90 (+1.49%)
Downtrend Call Working As Sage Therapeutic Stock Falls 27.9% (SAGE)

SmarTrend identified a Downtrend for Sage Therapeutic (NASDAQ:SAGE) on November 13th, 2018 at $113.70. In approximately 1 month, Sage Therapeutic has returned 27.93% as of today's recent price of $81.94....

SAGE : 133.90 (+1.49%)
Today's Research Reports on Trending Tickers: Sage Therapeutics and Altimmune

NEW YORK, NY / ACCESSWIRE / December 14, 2018 / U.S. markets finished modestly higher on Thursday as investors continue to worry about trade tensions between the U.S. and China. The Dow Jones Industrial...

SAGE : 133.90 (+1.49%)
Shares of Spark Therapeuti Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (ONCE , ATRA , SAGE , EPZM , ALNY )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ONCE : 43.96 (+2.88%)
SAGE : 133.90 (+1.49%)
ATRA : 37.25 (+2.53%)
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 8.51 (+4.03%)
EPAY : 49.40 (+1.65%)
EXAS : 76.00 (-1.41%)
WYNN : 113.13 (+4.97%)
HMSY : 28.93 (+0.84%)
GLT : 11.76 (-0.08%)
MHK : 124.88 (+0.68%)
BBW : 4.94 (-1.59%)
CDW : 81.25 (+0.94%)
COUP : 67.88 (-0.73%)
QTWO : 52.95 (+0.32%)
DENN : 17.73 (+0.06%)
MYL : 29.37 (+0.07%)
DFRG : 8.26 (+2.10%)
GCAP : 6.17 (+2.49%)
FEYE : 16.30 (-1.39%)
MXIM : 52.38 (+1.33%)
POL : 30.74 (+0.72%)
AN : 37.08 (+0.62%)
TWO : 14.02 (+0.29%)
HUBG : 41.38 (+1.47%)
AR : 10.99 (+0.46%)
RE : 213.02 (-1.14%)
NNBR : 8.66 (-0.12%)
ARE : 121.03 (+0.08%)
CVI : 37.30 (+0.81%)
CERS : 5.77 (+1.58%)
NDAQ : 81.36 (+0.39%)
ELLI : 68.89 (+0.86%)
BLDR : 12.41 (+1.64%)
EGRX : 43.35 (+3.19%)
RGLD : 82.42 (+1.28%)
PRGO : 45.18 (-0.04%)
PENN : 23.99 (+1.70%)
NTAP : 60.89 (-2.51%)
IBM : 121.33 (-0.33%)
NTRI : 43.67 (-0.05%)
BANR : 54.22 (+1.54%)
CWT : 45.89 (+0.64%)
STAA : 32.85 (+3.07%)
ATHN : 133.57 (+0.10%)
CL : 61.83 (-0.63%)
TFSL : 16.62 (+0.30%)
UFPI : 28.32 (+0.04%)
SDRL : 9.56 (-0.31%)
GOV : 6.87 (-5.50%)
HQY : 57.32 (+1.60%)
IPGP : 128.31 (+1.91%)
MINI : 35.56 (-0.34%)
CMTL : 25.06 (+0.48%)
CHD : 66.82 (-0.83%)
GPI : 59.46 (+0.25%)
HRL : 43.39 (-0.23%)
RARE : 51.47 (+0.53%)
MLI : 25.18 (+2.32%)
GPS : 24.80 (-0.44%)
CHS : 5.94 (+1.89%)
RYAM : 13.17 (+1.07%)
PBI : 7.45 (+3.04%)
NUVA : 46.85 (+0.97%)
IMDZ : 1.40 (+2.19%)
CAMP : 14.19 (+0.57%)
NOC : 257.08 (-0.72%)
AEL : 30.34 (+1.64%)
EBIX : 49.16 (+1.11%)
DISCA : 27.22 (+0.44%)
GPOR : 8.79 (+1.74%)
BGS : 30.47 (+0.53%)
TECH : 158.87 (+0.04%)
PCH : 34.45 (+1.03%)
NOV : 29.54 (+0.78%)
TECD : 92.04 (+0.19%)
DISCK : 25.18 (+0.20%)
DECK : 113.66 (-0.18%)
NOW : 188.75 (+0.21%)
MGLN : 61.79 (+1.20%)
IEX : 136.10 (+1.08%)
PTC : 86.93 (+0.68%)
AVT : 41.71 (+0.80%)
RGS : 19.09 (+1.33%)
BSFT : 54.95 (+0.09%)
FOSL : 17.30 (+0.58%)
WAL : 43.54 (+1.44%)
IVR : 15.76 (+0.57%)
ENR : 47.12 (+0.64%)
ISBC : 11.65 (+0.87%)
SHOO : 30.99 (-0.42%)
HDP : 14.68 (+1.80%)
AWK : 91.63 (+0.23%)
OMED : 0.78 (+2.63%)
LADR : 16.70 (-0.06%)
BIG : 31.08 (-0.92%)
WY : 24.14 (+0.12%)
JBLU : 17.50 (+1.98%)
GNMK : 5.86 (-2.17%)
FORM : 13.60 (+0.29%)
PFSI : 20.71 (-0.24%)
NEWM : 13.14 (+0.31%)
KFRC : 32.50 (+0.22%)
HOLX : 43.05 (+0.26%)
TMK : 80.95 (+0.56%)
AXTA : 24.59 (+1.57%)
PGEM : 21.65 (unch)
CLH : 55.80 (-0.36%)
CLI : 20.15 (+0.60%)
NRG : 40.84 (+0.99%)
CLGX : 35.47 (+0.94%)
SFLY : 44.21 (+1.19%)
ICUI : 232.65 (+0.69%)
CARA : 15.43 (+1.51%)
WTR : 34.02 (+0.21%)
NTGR : 37.69 (-0.13%)
OLED : 97.57 (+1.66%)
VNDA : 29.72 (+1.47%)
HIBB : 14.97 (-3.61%)
FFBC : 25.46 (+0.91%)
DLTR : 94.85 (-1.15%)
EQT : 21.05 (+0.48%)
OMER : 13.04 (-6.86%)
KTOS : 14.81 (-0.40%)
SRCL : 40.60 (+1.12%)
GES : 21.95 (+1.48%)
KMX : 63.47 (-1.43%)
PLAB : 10.53 (+1.54%)
NCS : 7.84 (+1.82%)
MAR : 109.92 (-0.24%)
MRVL : 16.80 (-0.24%)
UAL : 86.90 (+7.02%)
CNK : 40.05 (+0.38%)
NATH : 73.13 (-0.52%)
TPH : 12.72 (+0.87%)
OCUL : 4.00 (+0.25%)
SKYW : 48.15 (+2.80%)
HIVE : 3.51 (+1.45%)
GAIA : 11.64 (+3.56%)
ESRX : 92.33 (-3.62%)
PHM : 27.79 (-1.00%)
EBS : 66.70 (+3.03%)
CACI : 149.50 (+0.20%)
SAVE : 60.98 (+4.13%)
EZPW : 8.90 (+1.48%)
TPX : 49.36 (+0.86%)
KLAC : 92.25 (-0.29%)
ULTA : 278.72 (+0.08%)
WWE : 82.14 (+1.20%)
ESV : 4.45 (-0.67%)
LTRPA : 16.70 (+0.18%)
DAL : 48.81 (+2.05%)
BMY : 49.36 (-0.72%)
ECL : 150.48 (+0.30%)
CHRW : 85.43 (+0.23%)
WWW : 32.58 (+0.71%)
ETH : 18.40 (+1.21%)
IART : 46.42 (+1.20%)
LE : 16.03 (+2.76%)
LH : 133.13 (+0.37%)
HZO : 20.64 (+1.52%)
MTD : 582.09 (unch)
OSTK : 14.55 (-0.61%)
LDOS : 56.03 (+1.16%)
SAGE : 133.90 (+1.49%)
CIEN : 37.72 (+0.24%)
MTW : 15.31 (+1.66%)
AMC : 14.54 (+1.61%)
NDLS : 7.17 (-0.69%)
EFII : 22.79 (-16.15%)
SIVB : 223.89 (+2.37%)
MU : 34.08 (+0.26%)
DSW : 26.52 (+0.11%)
VRNT : 45.27 (-0.72%)
OII : 15.75 (-0.25%)
SAFM : 114.04 (-0.21%)
DATA : 120.96 (-1.10%)
TLYS : 12.01 (+0.59%)
TREE : 272.73 (+2.63%)
TRUP : 27.70 (-0.57%)
AMCX : 63.44 (+0.84%)
EXPD : 67.41 (+0.61%)
SUPN : 37.82 (-0.03%)
NBIX : 88.38 (+0.78%)
SAIC : 63.63 (+0.54%)
CBM : 43.49 (+1.73%)
BURL : 164.15 (-0.15%)
AMED : 125.51 (+0.40%)
EXPR : 5.28 (+2.33%)
SBH : 17.59 (+0.57%)
ATSG : 23.43 (-0.42%)
PLT : 35.62 (+0.39%)
QDEL : 53.36 (+0.06%)
NLNK : 1.55 (+0.65%)
STMP : 173.25 (+0.43%)
IPCC : 142.80 (+0.32%)
BMTC : 36.95 (+1.32%)
STML : 9.96 (+0.20%)
EGL : 29.10 (+0.24%)
LUV : 50.60 (+2.00%)
CCL : 52.50 (-0.79%)
INOV : 14.76 (+2.93%)
COTY : 7.12 (-2.33%)
MGM : 27.76 (+1.54%)
AKBA : 6.18 (+0.65%)
LGIH : 56.77 (-0.44%)
CDNS : 45.09 (-0.40%)
CRZO : 12.47 (-0.56%)
TEN : 32.53 (+1.88%)
HAIN : 18.31 (+0.72%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators mostly agree with the trend.

See More Share

Trade SAGE with:

Business Summary

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. Its initial product...

See More

Key Turning Points

2nd Resistance Point 138.17
1st Resistance Point 135.06
Last Price 133.90
1st Support Level 127.76
2nd Support Level 123.57

See More

52-Week High 195.97
Fibonacci 61.8% 151.62
Fibonacci 50% 137.93
Last Price 133.90
Fibonacci 38.2% 124.23
52-Week Low 79.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar